Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer

被引:33
作者
Inoue, Kazushi [1 ]
Fry, Elizabeth A. [1 ]
机构
[1] Wake Forest Univ Hlth Sci, Dept Pathol, Med Ctr Blvd, Winston Salem, NC 27157 USA
关键词
splicing; oncogene; tumor suppressor gene; cancer; prognosis; DMP1 (DMTF1); ARF; MDM2; p53; INDEPENDENT PROGNOSTIC MARKER; TRANSCRIPTION FACTOR DMP1; CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; P53; ISOFORMS; BREAST-CANCER; GENOMIC ORGANIZATION; GENE-EXPRESSION; DOWN-REGULATION; CRITICAL ROLES;
D O I
10.1002/ijc.30003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Alternative splicing (AS) of mRNA precursors is a ubiquitous mechanism for generating numerous transcripts with different activities from one genomic locus in mammalian cells. The gene products from a single locus can thus have similar, dominant-negative or even opposing functions. Aberrant AS has been found in cancer to express proteins that promote cell growth, local invasion and metastasis. This review will focus on the aberrant splicing of tumor suppressor/oncogenes that belong to the DMP1-ARF-MDM2-p53 pathway. Our recent study shows that the DMP1 locus generates both tumor-suppressive DMP1 (p53-dependent) and oncogenic DMP1 (p53-independent) splice variants, and the DMP1/ ratio increases with neoplastic transformation of breast epithelial cells. This process is associated with high DMP1 protein expression and shorter survival of breast cancer (BC) patients. Accumulating pieces of evidence show that ARF is frequently inactivated by aberrant splicing in human cancers, demonstrating its involvement in human malignancies. Splice variants from the MDM2 locus promote cell growth in culture and accelerate tumorigenesis in vivo. Human cancers expressing these splice variants are associated with advanced stage/metastasis, and thus have negative clinical impacts. Although they lack most of the p53-binding domain, their activities are mostly dependent on p53 since they bind to wild-type MDM2. The p53 locus produces splice isoforms that have either favorable (/ at the C-terminus) or negative impact (40, 133 at the N-terminus) on patients' survival. As the oncogenic AS products from these loci are expressed only in cancer cells, they may eventually become targets for molecular therapies.
引用
收藏
页码:33 / 41
页数:9
相关论文
共 88 条
  • [21] Intronic sequence variants of the CDKN2A gene in melanoma pedigrees
    Harland, M
    Taylor, CF
    Bass, S
    Churchman, M
    Randerson-Moor, JA
    Holland, EA
    Mann, GJ
    Bishop, DT
    Bishop, JAN
    [J]. GENES CHROMOSOMES & CANCER, 2005, 43 (02) : 128 - 136
  • [22] Hirai H, 1996, MOL CELL BIOL, V16, P6457
  • [23] Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
    Hofstetter, G.
    Berger, A.
    Schuster, E.
    Wolf, A.
    Hager, G.
    Vergote, I.
    Cadron, I.
    Sehouli, J.
    Braicu, E. I.
    Mahner, S.
    Speiser, P.
    Marth, C.
    Zeimet, A. G.
    Ulmer, H.
    Zeillinger, R.
    Concin, N.
    [J]. BRITISH JOURNAL OF CANCER, 2011, 105 (10) : 1593 - 1599
  • [24] Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
    Hofstetter, G.
    Berger, A.
    Fiegl, H.
    Slade, N.
    Zoric, A.
    Holzer, B.
    Schuster, E.
    Mobus, V. J.
    Reimer, D.
    Daxenbichler, G.
    Marth, C.
    Zeimet, A. G.
    Concin, N.
    Zeillinger, R.
    [J]. ONCOGENE, 2010, 29 (13) : 1997 - 2004
  • [25] Dmp1 and tumor suppression
    Inoue, K.
    Mallakin, A.
    Frazier, D. P.
    [J]. ONCOGENE, 2007, 26 (30) : 4329 - 4335
  • [26] Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1
    Inoue, K
    Roussel, MF
    Sherr, CJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) : 3993 - 3998
  • [27] Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas
    Inoue, K
    Zindy, F
    Randle, DH
    Rehg, JE
    Sherr, CJ
    [J]. GENES & DEVELOPMENT, 2001, 15 (22) : 2934 - 2939
  • [28] Inoue K, 2000, GENE DEV, V14, P1797
  • [29] Regulation of the CD13/aminopeptidase N gene by DMP1, a transcription factor antagonized by D-type cyclins
    Inoue, K
    Sherr, CJ
    Shapiro, LH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) : 29188 - 29194
  • [30] Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism
    Inoue, K
    Sherr, CJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (03) : 1590 - 1600